| 000 | 01413nam a2200229 4500 | ||
|---|---|---|---|
| 001 | 363046 | ||
| 090 | _a363046 | ||
| 100 | _a20170504u y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aDrug legislation in New Zealand _fKeith Bedford |
||
| 311 | _aIn: Forensic toxicology : drug use and misuse / ed. Susannah Davies, Atholl Johnston and David Holt. - Cambridge : The Royal Society of Chemistry, 2016. ISBN 978-1-78262-156-0. p. 356-369. | ||
| 463 | _tIn: Forensic toxicology : drug use and misuse / ed. Susannah Davies, Atholl Johnston and David Holt. - Cambridge : The Royal Society of Chemistry, 2016. ISBN 978-1-78262-156-0. p. 356-369.. | ||
| 330 | _aHistorical background and New Zealand Drug Policy Framework. Scheduling of substances under the MoDA. Controlled drug analogue provisions of the MoDA. The appearance of "party drugs" and the introduction of "restricted substance" class. Consequences. The rise of "synthetic cannabinoid" products. Introduction of "Temporary class drug orders". The Psychoactive substances regime declaration of interest. References. | ||
| 606 |
_aESTUPEFACIENTE _9343050 |
||
| 606 |
_aSUBSTÂNCIA PSICOTRÓPICA _9343195 |
||
| 606 |
_aTOXICODEPENDÊNCIA _9225048 |
||
| 606 |
_aLEGISLAÇÃO PENAL _9275821 |
||
| 606 |
_aNOVA ZELÂNDIA _9337949 |
||
| 700 |
_aBEDFORD _bKeith _9343196 |
||